What to Expect:
This program examines breast cancer genes beyond BRCA 1 and BRCA 2 and will focus on risk and medical management associated with these mutations.

Learning Objectives:

  • Examine current literature and emerging data surrounding hereditary breast cancer risk assessment and testing.
  • Characterize the clinical presentation and cancer risks associated with breast cancer genes outside of BRCA1/2.
  • Outline updated management and risk reduction strategies for carriers of mutations in moderate penetrance breast cancer genes.


Shrutika Yeola MMSC CGC
This nursing continuing professional development activity is approved for 1.25 contact hours from Oregon Nurses Association (ONA), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC). Contact hours will be awarded to participants who view the entire program recording and complete the post-activity survey.

Click here after viewing the webinar to complete the survey:
Take survey

Please pay close attention to the instructions for receiving your certificate at the end of this survey. Once you have completed this survey in entirety you will have an option to print or save the image of the certificate. We recommend that you complete this from a desktop or your laptop computer for best quality and options for saving this file.

Please read the instructions below carefully to obtain your certificate.

IMPORTANT: You must save the image at this time to obtain this certificate for your records.

***You must complete the webinar and survey no later than June 20th, 2025 to claim credit***

Myriad Genetics Lab, a diagnostic lab that does not sell proprietary products, is an eligible organization according to the American Nurses Credentialing Center criteria. There are no relevant financial relationships with any individuals in the position to control content for this educational activity.

Questions or comments?

Webinar Questions